Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Related Posts
What to Know About the Hepatitis A Outbreak in L.A. County
A highly contagious liver infection is surging among groups who are not typically at risk. At least seven people have…
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
A committee of independent advisers to the Food and Drug Administration voted unanimously on Monday that the benefits outweigh the…
An Ozempic Relative Slowed Parkinson’s Disease in a Small Study
In 1817, James Parkinson expressed a hope about the disease that is named after him. He thought that at some…